Experimental analysis of enzymatic transition-state structures uses kinetic isotope effects (KIEs) to report on bonding and geometry differences between reactants and the transition state. 
INTRODUCTION
Research in the mechanisms of enzymatic catalysis has redoubled with new efforts in computational chemistry proposing explanations for catalytic rate enhancement and barrier crossing (1) (2) (3) (4) (5) , in systems biology for annotation of unassigned open reading frames (6, 7) , in chemical library screening for new enzyme inhibitors as pharmacology leads (8, 9) , in the evolution of enzyme structure and function (10, 11) , and in the de novo design of enzymatic activity (12, 13) . Catalytic efficiency and the nature of enzymatic transition states are pertinent to each effort. Only by efficient formation of the transition state can enzymes serve their catalytic function. Any interference in catalytic function constitutes an approach to potential pharmacophores. Enzymes remain important pharmaceutical targets as approximately one-third of current drugs act as enzyme inhibitors (14, 15) . All biological function is linked to catalytic activity, and increased understanding in genetics invariably generates new questions relative to the catalysts involved in higher-order regulatory processes.
Chemical transition states have short lifetimes of a few femtoseconds, the time required for electron redistribution and the time to convert the restoring mode of a chemical bond to a translational mode (16, 17) . Enzymes have functional turnover numbers (k cat ) near the millisecond timescale; thus, the transition-state lifetime occupies only about 10 −12 of the reaction coordinate cycle (Figure 1 ). An enzyme fully saturated with reactants and engaged in maximal catalysis will therefore have about 1 part in a trillion occupied by the transition-state complex with the remainder in ground-state complexes. Thus, spectroscopic or static techniques are incapable of characterizing enzymatic transition-state complexes. Although claims have been made for trapping actual transition-state species in crystallographic structures (e.g., References 18 and 19), these claims have not withstood critical analysis (20, 21) . Relative timescales for motions involved in enzymatic catalysis and interactions of transitionstate analogs (adapted from Reference 51 with permission). Note the 10 13 timescale difference between k cat for PNP and TS lifetimes (blue). The red bar indicates typical enzymatic k cat ranges. fs, femtosecond; Hb, hemoglobin; μs, microsecond; ms, microsecond; ns, nanosecond; PNP, purine nucleoside phosphorylase; ps, picosecond; TIM, triose phosphate isomerase; TS, transition state.
Kinetic isotope effect (KIE):
a ratio of reaction rates for labeled ( Indirect methods used to characterize transition states have traditionally been borrowed from physical organic chemistry, including chemical reactivity relationships (22, 23) . Kinetic isotope theory and kinetic isotope effects (KIEs) were first developed for isotope fractionation and later used to deduce chemical mechanisms in organic chemistry and transition-state features for solution-based chemical reactions (24) (25) (26) (27) . The application of isotope effects to enzymatic reactions became more practical with the publication of books summarizing the theory and methods for approaching problems with isotope effects in enzymology (28, 29) . With the current applications of KIE experiments exemplified here, technology is now available to understand the structural features of enzymatic transition states.
Enzymes are remarkable for catalytic rate enhancement and for their ability to overcome the single large transition-state energetic barrier of solution reactions by creating multiple steps with smaller barriers. Often, protein conformational changes or rates of reactant release limit the reaction rates and thereby obscure the values of the KIE (intrinsic values) arising from the chemical step. Intrinsic isotope effects are essential for interpretation of KIE information into transition-state structures, and methods to address this problem evolved with the application of transition-state theory to enzymes (30, 31) . Multiple KIE approaches were used to map general features of enzymatic transition states before computational approaches were available to fit a family of intrinsic KIEs to a specific transition-state structure (32) . Despite the long history of KIE applications to enzymatic reactions, the technology is still evolving. For example, a general assumption has been that binding isotope effects (BIEs) could be ignored. BIEs are now known to be significant in many, and possibly all, enzymatic reactions and often contribute to the calculated intrinsic KIE values (33, 34) . BIEs can now be used to provide insights about ground-state (thermodynamic) interactions.
This article provides some examples of the combined experimental-computational approaches to establish transition-state information for specific enzymatic reactions and the use of transition-state structure to design transition-state analogs. The focus is on transition states for a family of N-ribosyltransferases. Despite this focus, the KIE method of transition-state analysis is general and relies only on the ingenuity of the investigator to select appropriate targets, resolve features of the transition state, and synthesize new transition-state analogs. Isotope effects and Molecular electrostatic potential: electron force applied to a positive charge in a defined position relative to a molecule transition-state analogs also provide research tools to understand catalyst function.
FROM KINETIC ISOTOPE EFFECTS TO TRANSITION-STATE STRUCTURE
KIE measurements compare reaction rates of isotope-labeled and natural abundance reactants. When the reactants compete, the results yield KIEs on k cat /K m and include all steps between reactants free in solution and the first irreversible step in the reaction. These methods have been described (35) (36) (37) (38) . Recent application of NMR methods allows natural abundance determination of many isotope effects simultaneously or permit accurate analysis by NMR neighbor chemical-shift methods (39) (40) (41) . Larger isotope effects from solvent 2 H 2 O or for hydride transfer mechanisms can be measured using labeled and unlabeled reactants in separate experiments to obtain distinct values for isotope effects on k cat and K m . Intrinsic KIEs arise from the difference in bond vibrational environment for an atom in the reactant state compared to its environment at the transition state and thus gives an atom-by-atom description of the transition state. Multiple isotope effects, taken from molecular sites that change in bond vibrational environments between reactant and transition states, can be used to recreate a full model of the transition state.
Matching Kinetic Isotope Effects to Transition-State Models
Atom-by-atom KIE values are converted to a specific static model with fixed bond angles and lengths by computational matching to a quantum chemical model of the reaction of interest. A typical approach is to explore the reaction of interest in the Gaussian computational suite using the B3LYP method with a 6-31G * basis set (defining the level of computational theory), although other levels of theory can be used and the method is not strongly dependent on the basis set (42) (43) (44) . Reactants, transition state, and product geometries are located as the global minima. Transition-state structures are located with a single imaginary frequency, characteristic of true potential energy saddle points. The experimental intrinsic KIEs are then matched in fixed-distance optimizations using a grid of possible transition structures. Fixed bonds are used only along the reaction coordinate (the reaction coordinate is defined as the sites of bond making and bond breaking, for example, the bonds to the leaving group and to the attacking nucleophile in ribosyl transferases). The computed structures are relaxed in other dimensions, and isotope effects are calculated for each transition state using QUIVER or ISOEFF98 software (45, 46) . If indicated by structural data and if needed to obtain a KIE match, hydrogen bonds or other interactions from catalytic site residues can be added. Transition-state models matching the intrinsic KIE can be recalculated at the highest practical level (typically, B3LYP/6-31+G * * ) to obtain the final transition-state model.
Electrostatic Potential Maps
The CUBE subprogram from Gaussian can be used to generate the molecular electrostatic potential surfaces of transition-state structures using the formatted checkpoint files from geometry optimization. The molecular electrostatic potential surfaces can be visualized at the van der Waals surface or closer to the nuclei (isovalues of 0.040 and 0.068, respectively) using GaussView 3.09 (available in Reference 47).
DESIGN OF TRANSITION-STATE ANALOGS
The goal of transition-state analog design is to create stable chemical structures with van der Waals geometry and molecular electrostatic potential surfaces as close as possible to those of the transition state. The original hypothesis for binding of transition-state analogs invoked tight binding of the transition state as the rationale for the tight binding of transitionstate mimics (48) (49) (50) 
Predictive Binding
Before synthetic chemistry efforts are applied to putative transition-state analogs, quantitative measures of similarity to the transition state are useful. One method ranks the similarity of proposed analogs by parameters of geometry and electrostatic potential surface against the same parameters for transition-state analogs (53, 54) . As geometry and electrostatics are the dominant parameters for ligand recognition, molecules more similar to the transition state are bound more tightly. For example, using these similarity parameters from 0 (no similarity) to 1.0 (identity to the transition state), the substrate inosine for bovine purine nucleoside phosphorylase (PNP) shares a 0.483 similarity, whereas the analog immucillin-H (ImmH) shares a similarity of 0.723 to the transition state, providing a dissociation constant of 23 picomolar (pM) and a K m /K d ratio of 739,000 (Figure 2) (55) . Values for chemically stable transition-state analogs near 1.0 are not possible because the features of the transition state include nonequilibrium bond lengths and partial charges that cannot be reproduced in stable chemical mimics.
A second predictive affinity method uses neural network similarity measures to rank geometry and electrostatic potential surface parameters from a known set of inhibitors (including some with features of the transition state) and compare these parameters to those from proposed inhibitors prior to chemical synthetic efforts (56) . This approach faithfully predicts the binding affinity of a family of un- 
Figure 2
Binding free energy ( G/RT ) and molecular electrostatic potential surface similarity S e for inosine, immucillin-H, and the transition state for bovine purine nucleoside phosphorylase (modified and reprinted from Reference 55 with permission).
known inhibitors for the IU-nucleoside hydrolase from Crithidia fasciculata (Figure 3 ) (57) .
Selecting Targets
Emphasis on the N-ribosyltransferases in this review is not a random choice. Good target candidates for transition-state analog design should have altered geometry and/or charge on conversion from reactants to the transition state. Glycosytransferases generally share these properties. Thus, most sugar transferases form transition states with cationic charge at the anomeric carbon, and the geometry is altered at this center from sp 3 (tetrahedral geometry) in the reactant sugar to sp 2 (trigonal planar geometry) at the transition state (58) (59) (60) 
Relative charge

Figure 3
A molecular electrostatic potential and geometric input for inhibitor recognition by nucleoside hydrolase using a neural training network. The surface (outer sphere of golden squares) is imprinted with molecular electrostatic potentials, where red indicates a partial positive charge, and purple indicates a partial negative charge relative to the average charge at the van der Waals surface. The transition state (left) is similar to the high-affinity inhibitor (middle, K d = 4 nM) but different from the low-affinity inhibitor (right, K d = 18 mM). Modified from Reference 57 and reprinted with permission. nM, nanomolar; mM, millimolar. 
TRANSITION-STATE STRUCTURES AND ANALOGS
Human and Bovine Purine Nucleoside Phosphorylases
The human genetic deficiency of PNP was linked to T-cell immune deficiency by the early studies of Giblett et al. (63) . Subsequent studies revealed that the accumulation of 2 -deoxyguanosine in blood is specifically toxic by causing excess dGTP accumulation in activated T cells (64) . Bovine PNP was used as a model for human PNP and assumed to form a similar transition state because of the 87% amino acid sequence identity (65, 66) . KIE values and transition-state analysis for the arsenolysis reaction revealed an early dissociative transitionstate structure with a significant bond order to the departing hypoxanthine at the transition state (Figure 4) . Electrostatic comparison of the transition state and analogs indicated a good match between ImmH and the transition state for bovine PNPs, and indeed, ImmH is a 23-pM inhibitor of bovine PNP and gives a 739,000 K m /K i value (Figures 3 and 4) . As bovine PNP was intended as a surrogate for human PNP, the 56-pM dissociation constant of ImmH for human PNP was a concern because of its lower affinity for the desired target, especially because there is 100% amino acid conservation for inhibitor contacts at the catalytic sites (67) . This difference in ImmH binding for the human and bovine PNP isozymes suggested the possibility of distinct transition states.
Intrinsic KIE values for bovine and human PNPs were different (Figure 4) . Because intrinsic KIEs report on the bond vibrational status at the transition state, the primary data set established different transition-state structures for these closely related enzymes (Figure 4) . The transition state for human PNP is a fully formed ribocation with the cationic charge located primarily at C1 (the anomeric carbon), has a fully dissociated bond of 3Å to the hypoxanthine, and shows no significant participation of the arsenate nucleophile. The physiological substrate for human PNP is 2 -deoxyguanosine; thus, the transition state for human PNP also forms Intrinsic kinetic isotope effects (in percentages) for bovine (upper left, in red ) and human (upper right) purine nucleoside phosphorylases (PNPs). Intrinsic isotope effects shown in blue for human PNP are significantly different from those for bovine PNP. Reaction coordinate bond lengths (middle) give rise to the molecular electrostatic potentials (bottom) for the transition states (TSs) and transition-state analogs, immucillin-H (ImmH), and 4 -deaza-1 -aza-2 -deoxy-1 -(9-methylene)immucillin-H (DADMe-ImmH). Blue atoms (middle) are sties most changed by the formation of the transition state. pM, picomolar.
efficiently with 2 -deoxyribosyl sugars. These distinct features of the transition state can be matched with DADMe-ImmH [4 -deaza-1 -aza-2 -deoxy-1 -(9-methylene)immucillin-H] (Figures 4 and 5 ). DADMe-ImmH shows higher affinity for human than bovine PNP and binds 2,400,000 times tighter than substrate according to the K m /K d ratio (68) .
Lessons from comparisons of bovine and human PNPs are that distinct transition-state structures can be formed by closely related enzymes with nearly identical catalytic sites 
ImmH
pM
SerMe-ImmH 5 pM
DATMe-ImmH 9 pM
DADMe-ImmH 9 pM
Figure 5
Four generations of transition-state analogs for human purine nucleoside phosphorylases together with their dissociation constants. DADMe-ImmH, 4 -deaza-1 -aza-2 -deoxy-1 -(9-methylene)immucillin-H; ImmH, immucillin-H; pM, picomolar; SerMe-ImmH, the seramide substituent of 9-methylene-9-deazahypoxanthine.
and that transition-state information from KIEs provides a tool for the design of specific transition-state analogs. Distinct transition states from enzymes with near-identical catalytic sites suggest involvement of the protein architecture in transition-state formation. By replacing remote amino acids (>25Å from the catalytic sites) in human PNP with those of bovine PNP, a chimeric enzyme was formed with altered dynamic properties and a transition state distinct from either parent (69, 70) . ImmH contains four asymmetric carbon centers and reactive nitrogen and oxygen groups that require protection, making the chemical synthesis difficult (71, 72) . Use of 2 -deoxynucleosides by human PNP permits design of transition-state analogs with the elimination of one stereocenter, and replacing the C1 -anomeric carbon with nitrogen eliminates a second; thus, DADMe-ImmH has only two stereocenters and can be synthesized using the Mannich reaction without protecting the chemically reactive nitrogen and oxygen atoms ( Figure 5 ) (73) . Replacing the hydroxypyrrolidine ribocation mimic of DADMe-ImmH with acyclic groups further simplified these analogs and has generated third-and fourth-generation inhibitors exemplified by DATMe-ImmH and SerMe-ImmH ( Figure 5 ). These inhibitors show similar picomolar binding affinity to human PNP and are increasingly accessible to synthetic chemistry (74, 75) . Crystallographic analysis of human PNP with all four generations of the immucillins shows common features linked to their tight binding. Most important is the ability to form an ion pair between the bound N-ribocation mimic and the phosphate anion at the catalytic site. In ImmH, this distance is 3.3Å and is shorter than with the other analogs (67). The 9-deazahypoxanthine group is common to all inhibitors, but in ImmH, contacts to catalytic site groups are less optimal than for the others. The geometry of ImmH in the dimension of the reaction coordinate (distance from the N4 -cation to N7) is too short to permit optimal contacts to both 9-deazahypoxanthine and the ribocation mimic. Thus, human PNP is resistant to flex beyond the extended geometry of a fully dissociated transition state in this dimension. Inhibitors longer in their reaction coordinate dimension by addition of the methylene bridge more optimally capture the interactions between the inhibitor and the catalytic site.
Transition-state analogs are not useful in drug development unless biological availability permits access to the target. In the case of human PNP, this means access to all tissues because the enzyme is widely distributed. From characterization of human PNP genetic mutants, it is known that >95% inhibition of PNP is needed to cause acumulation of 2 -deoxyguanosine and thereby block T-cell proliferation (76) . ImmH enters human cells on the purine nucleoside transporters to provide access to all tissues (77) .
Although mechanisms of transport for other immucillins have not been reported, singledose oral administration of DADMe-ImmH caused rapid inhibition of PNP in mice as indicated by complete inhibition of PNP in mouse blood. Recovery of half-normal PNP activity requires 11.5 days and parallels erythrocyte replacement. Thus, DADMe-ImmH stays on its biological target until cells are replaced (68) . Imm-H and DADMe-ImmH show low toxicity in animal studies. ImmH is in clinical trials for T-cell malignancies under the name of Forodesine TM , and DADMe-ImmH is in clinical trials for gout under the name BCX4208 (78, 79) . 
Figure 6
The role of 5-methylthioadenosine phosphorylase (MTAP) in polyamine synthesis, methionine, ATP, and S-adenosylmethionine (SAM) salvage (figure modified and reprinted from Reference 87 with permission). 
-
Human 5 -Methylthioadenosine Phosphorylase
The production of 5 -methylthioadenosine (MTA) in humans occurs only in the pathway for conversion of S-adenosylmethionine (SAM) to polyamines (Figure 6 ). The sole metabolic fate for MTA is conversion to adenine and 5-methylthio-α-D-ribose 1-phosphate by 5 -methylthioadenosine phosphorylase (MTAP). These products of the MTAP reaction are recycled to ATP and methionine, metabolites that can be recycled to SAM (80) . MTAP therefore serves as an essential part of adenine, methionine, and SAM salvage pathways. The MTAP reaction is linked to biosynthetic methylation reactions and regulatory methylations of CpG sites in DNA and to protein methylation. Inhibitors of these processes are proposed to function as anticancer agents (81, 82) . The polyamine pathway is also an anticancer target.
Inhibition of MTAP causes MTA to accumulate and causes product inhibition of polyamine synthetases (82, 83) .
KIEs for human MTAP and computational modeling (see above) provided a transitionstate structure for the arsenolysis of MTA (84) . Intrinsic KIEs indicated a dissociative S N 1 transition state for MTAP (Figure 7) . The anomeric carbon of 5-methylthioribose is converted to a cationic center at the transition state, and bond loss to the adenine leaving group is complete. An unusual feature of the KIEs is the large [9- 15 N]MTA value of 3.9%, which indicates anionic adenine at the transition state. 
Figure 7
The transition state and transition-state analogs for the arsenolysis reaction of human 5 -methylthioadenosine phosphorylase (MTAP). The intrinsic kinetic isotope effects used in transition-state analysis are shown on the upper right, and the inhibitors are shown below. Inhibitor features that mimic the transition state are in blue. pClPhT-is a 4-chloro-phenylthio group. MT, methylthio; pM, picomolar. polarization or ionization of the ribosyl 3 -OH group. Ionization of the 3 -OH group suggests a zwitterionic ribosyl group with a 3 -endo conformation at the transition state.
The late S N 1 transition state for human MTAP suggested that analogs similar to DADMe-ImmH for human PNP, modified to reflect the substrate specificity of human MTAP, may capture transition-state features. The 9-deazaadenine ring and 5 -methylthio group mimic human MTAP substrates (85) . Analogs for the human MTAP transition state were synthesized and provide picomolar inhibitors (84) (85) (86) . MethylthioDADMe-immucillin-A (MT-DADMe-ImmA) is a transition-state analog of human MTAP and is a slow-onset, tightly binding inhibitor with a dissociation constant of 86 pM and is orally available in mice (Figure 7 ) (87) .
Screening of human cancer cell lines showed low toxicity for MT-DADMe-ImmA and MTA as individual agents. MT-DADMe-ImmA in combination with MTA causes growth inhibition in some cell lines and apoptosis in others. Human FaDu head and neck cancer cells, when treated with MT-DADMe-ImmA and MTA, revealed inhibition of cellular MTAP, increased cellular MTA concentrations, decreased polyamines, and increased rates of apoptosis. Implanted FaDu tumors in mouse xenografts were treated with MT-DADMeImmA, resulting in tumor remission with no apparent toxicity to the host (87) . In a related study with human lung cancer cell lines, MT-DADMe-ImmA inhibited growth of primary tumors in mice and decreased metastatic cancers to the lungs (88) .
Bacterial Methylthioadenosine/ Adenosylhomocysteine Nucleosidase Hydrolases
Induction of luminescence genes in Vibrio harveyi as a function of cell density in culture led to the discovery of quorum-sensing systems in bacteria (89) . When bacterial cell 5 -Methylthioadenosine/adenosylhomocysteine nucleosidase (MTAN): an enzyme that catalyzes the hydrolysis of 5 -methylthioadenosine (MTA) and adenosylhomocysteine to adenine and 5-methylthio-α-Dribose or ribosylhomocysteine populations reach critical levels, cells produce and detect signaling molecules known as autoinducers (AIs) to coordinate gene expression and regulate processes that are presumed to be beneficial for the colony (89) . Bacterial multidrug resistance has rapidly appeared with conventional cell-killing antibiotics, and overcoming this problem requires approaches that are nonlethal to bacteria to prevent development of resistance while blocking pathogenicity (90) (91) (92) (93) . Quorum sensing is linked to virulence but is not essential for growth, making it an attractive target.
One class of quorum-sensing molecules, the autoinducer-1 (AI-1) and autoinducer-2 (AI-2) molecules, is linked to SAM metabolism (Figure 8 hydrolyze both MTA and adenosylhomocysteine, are directly involved in the biosynthesis of autoinducers or in SAM recycling, and are essential for the production of autoinducer molecules (94) . AI-1 and AI-2 are synthesized from SAM; thus, MTAN inhibition was proposed to block both AI-1 and AI-2 production, thereby disrupting quorum sensing. Because MTANs are not found in humans, MTAN inhibitors are expected to block quorum sensing in bacteria without effects on human metabolism. Transition-state structures of bacterial MTANs were established by quantum chemical analysis using the intrinsic KIE values for MTANs from Escherichia coli, Streptococcus pneumoniae, and Neisseria meningitidis (95) (96) (97) . A comparison of the intrinsic KIE values is instructive (Figure 9) 
Figure 9
Kinetic isotope effect values (as percentages) used for transition-state analysis of the bacterial 5 -methylthioadenosine/adenosylhomocysteine hydrolases.
the leaving group is protonated at the the transition state. Ribose pucker at the transition state affects the 2 -3 H KIE, and the relatively small value of 4.4% indicated a H1 -C1 -C2 -H2 dihedral angle of 53
• at the transition state, a modest 3 -endo geometry. This transition state predicts that extended transition-state analogs, patterned after the DADMe-ImmH for human PNP, would resemble this transition state, and these compounds are powerful inhibitors (see below).
The intrinsic KIE values for S. pneumoniae MTAN are similar to those for the E. coli enzyme and also support a dissociative S N 1-like transition state with no significant covalent participation of the adenine leaving group or the attacking water nucleophile (96) . A quantum chemical model of the transition state as a ribooxacarbenium ion intermediate was found to fit the intrinsic KIEs. A 3 -endo conformation for the ribocation corresponding to H1 -C1 -C2 -H2 dihedral angle of 70
• is consistent with the KIEs. Although both E. coli and S. pneumoniae MTAN transition states exhibit fully developed ribocations, the 9-15 N KIEs differ considerably, 1.8% and 3.7%, respectively. The [9- 15 N]MTA isotope effect reports on the total bond order to N9 at the transition state and is influenced by the protonation state of the leaving group. The value of 3.7% found for the S. pneumoniae MTAN indicates that the adenine leaving group is not protonated at the transition state and therefore is proposed to depart as a catalytic-site-stabilized adenine anion. In this and other transition states, the influence of the virtual solvent (a dielectric constant) was varied as part of the modeling and did not influence calculated KIE values beyond experimental error. S. pneumoniae MTAN differs from most other purine N-ribosyltransferases but resembles human MTAP in the protonation state of the leaving group. Departure of a leaving group from an ion-pair transition state (cationic ribose and anionic adenine) is difficult and is consistent with the 10 3 -fold decrease in the catalytic efficiency of S. pneumoniae MTAN relative to that from E. coli. Because the interaction of transition-state analogs is also related to The MTAN inhibitors were tested for the ability to disrupt quorum sensing in E. coli and Vibrio cholerae. MT-DADMe-ImmA, EtTDADMe-ImmA, and BuT-DADMe-ImmA (see Figures 10 and 11) 50 values, and autoinducer production was blocked at nanomolar concentrations (94) . Similar results were obtained with enterohemorrhagic E. coli O157:H7. Inhibitor studies conducted in parallel with bacterial cells genetically deleted in MTAN affirmed the role of this pathway in quorum sensing and its potential as a target for bacterial quorum sensing (94) .
With the three MTAN transition states described above, the transition states for other members of the bacterial MTAN family can be predicted from MTAN affinity to transitionstate analogs. Thus, transition-state analogs with short distances between the ribocation mimic and leaving group mimic will bind better to the MTANs that form early transition states. Transition-state analogs with extended distances between the ribocation mimic and leaving group mimic will bind better to MTANs with fully dissociated transition states. This approach was tested on six MTANs, the three described above with known transition states and three MTANs with uncharacterized transition states. Using this approach, the transition states of N. meningitidis and Helicobacter pylori MTANs appear similar, and both are early dissociative. 
Ricin A Chain and Saporin
Ricin toxin A chain (RTA) and saporin are plant ribosome-inactivating proteins (RIPs) with catalytic activity for depurination of adenine residues from RNA, making them Nribosylhydrolases (99) . Biomedical interest in the RIPs arises from their use as anticancer agents when linked to monoclonal antibodies or other molecules designed to recognize cancer cells. Off-target toxicity causes vascular leak syndrome, an unacceptable side effect. Transition-state analogs that inhibit RIP activity following therapy are being explored to provide an approach to limit the side effects.
Ricin A chain shows high substrate specificity for a single adenine in the elongation factor-binding site of 28S ribosomal RNA located in a 5 -GAGA-3 tetraloop where the 5 -A is hydrolyzed. The transition state for depurination of stem-loop RNA by RTA was solved by KIEs using stem-loop RNA (5 -GGCGAGAGCC-3 ) with isotopically labeled adenosine at the depurination site (100). The KIEs of 16.3% for [1 - 3 H], −1.9% for [7- 15 N], 1.6% for [9- 15 N], −0.7% for [1 -14 C], and 1.2% for [2 - 3 H] demonstrated formation of an RNA ribooxocarbenium ion and adenine in equilibrium with the Michaelis complex (101) . The ribosyl ring pucker at the transition state was found to be 3 -endo, giving rise to the small [2 - 3 H] KIE. The unusual dihedral angle of approximately 50
• between C2 -H2 and the vacant p orbital of the anomeric carbon are consistent with the relatively rigid geometry of the stem-loop RNA backbone (Figure 12 ). An irreversible nonchemical step initiates water attack. RTA has a stepwise D N * A N mechanism, and the cationic intermediate has a finite lifetime. This study with RTA was the first to establish that KIEs and transition-state analysis could be extended to the reactions of nucleic acid chemistry.
Transition-state analysis for oligonucleotides was extended to DNA in a KIE and transition-state analysis study using RTA with stem-loop DNA as a slow substrate. Although the transition state for stem-loop RNA is constrained by the rigid RNA scaffold, stem-loop DNA is more flexible and permits formation of the most chemically stabilized geometry for the deoxyribocation at the transition state (Figure 12) (102) .
On the basis of transition-state structures of RTA with stem-loop RNA and DNA, ribocation characteristics with N7-protonated leaving groups are implicated as transition-state mimics. Because RTA is catalytically efficient only on stem-loop RNAs, loop mimics of the stemloop structures were constructed and tested as inhibitors using small stem-loop RNAs as substrates (103, 104) . Nanomolar inhibitors were Transition-state geometry for ricin A chain with stem-loop RNA (dark gray) and with stem-loop DNA (medium gray) superimposed on the crystal structure of stem-loop RNA geometry (light gray) (reprinted from Reference 102 with permission). Ribosyl carbons C1 and C5 as well as ribosyl oxygens O2 and O3 are shown for the two geometries of the transition state, 3 -exo for the transition state with RNA and 3 -endo for the transition state with DNA. 3 -Exo and 3 -endo ribosyl geometry refer to the 3 C being below or above the plane of the ribosyl ring formed by the other four atoms.
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achieved with an N-benzyl-hydroxypyrrolidine (N-Bn) transition-state analog at the RTA depurination site in a circular GAGA motif. A cyclic G(N-Bn)GA provided a new RTA inhibitory scaffold and the most powerful RTA inhibitor (K d = 70 nM) known. The transitionstate analysis and inhibitor design for RTA was done at pH 4.0, required for RTA activity on small stem-loop substrates. These inhibitors did not protect mammalian ribosomes from RTA at physiological pH values. Transitionstate inhibitor design was therefore extended to saporin, a RIP from the soapwort plant with the assumption that it forms a similar transition state.
Saporin-L1 from Saponaria officinalis (soapwort) leaves is highly active against small nucleic acid substrates and mammalian ribosomes and removes multiple adenines from RNA, including small linear sequences (105) . Linear, cyclic, and stem-loop oligonucleotide inhibitors containing 9-deazaadenine-9-methylene-N-hydroxypyrrolidine and based on the 5 -GAGA-3 sarcin-ricin tetraloop gave K d values in the range of 2 to 9 nM (Figure 13) . Under physiological pH values, these analogs bind up to 40,000-fold tighter than similar RNA substrates. Importantly, the destruction of ribosomes by saporin-L1 in rabbit reticulocyte translation was protected by these inhibitors (106) .
The availability of powerful inhibitors for ricin and saporin permitted the first crystal structures of RTA and saporin with oligonucleotides bound in the catalytic sites. The inhibitors resemble both the sarcin-ricin recognition sequence and the ribocation transition state established for RTA. RTA and saporin share unique purine-binding geometry at their catalytic sites with quadruple pi-stacking interactions between adjacent adenine and guanine bases and two conserved tyrosines (107) . An arginine at one end of the pi stack provides cationic polarization and is proposed to enhance the adenine leaving group ability (Figure 14) . Adenine leaving group activation dominates the reaction mechanism with no apparent features to assist in ribocation formation. Conserved glutamates activate the water nucleophile. Ricin A chain and saporin-L1 exemplify the ability of transition-state analogs to organize catalytic sites and permit mechanistically meaningful crystal structures.
Orotate Phosphoribosyltransferases
Orotate phosphoribosyltransferases from Plasmodium falciparum and human sources (PfOPRT and HsOPRT) use the pyrimidine nucleoside orotidine as a slow substrate for pyrophosphorolysis. Intrinsic KIEs were measured to provide the first enzymatic transition state using pyrophosphate as the nucleophile. PfOPRT and HsOPRT are characterized by late transition states with fully dissociated orotate, well-developed ribocations, and weakly bonded PPi nucleophiles (108) . The N-ribosidic bond to the leaving orotate is 2.8Å, whereas weak participation of the PPi nucleophile gave a bond distance of approximately 2.3Å (Figure 15) . These phosphoribosyltransferase transition states are similar to but occur earlier in the reaction coordinate than transition states for PfOPRT and HsOPRT previously determined with orotidine 5 -monophosphate and phosphonoacetic acid as substrates (109) and occur much later in the reaction coordinate than a transition-state structure reported for a bacterial OPRT using orotidine 5 -monophosphate and phosphonoacetic acid (110) . Similar transition states for PfOPRT and HsOPRT with different substrate analogs support similar transition-state structures imposed by the enzymes. Geometric constraints imposed by the catalytic sites may imprint these transition states.
GENERAL APPLICABILITY OF ENZYMATIC TRANSITION-STATE ANALYSIS
The examples provided above focus on Nribosyltransferases. However, the method can 
TRANSITION-STATE VERSUS GROUND-STATE COMPLEXES
Glycosyltransferases are known to pass through cationic transition states, and the resulting glycocations are often considered to be intermediates with significant lifetimes (111) . In some cases, experimental evidence exists for intermediate status; for example, in the case of ricin, a ribocationic intermediate is equilibrated with the Michaelis complex (101, 102) . A chemical model for N-ribosyl hydrolysis has been provided by the acid-catalyzed solvolysis of dAMP in 0.1 N HCl, where a deoxyribocation lifetime of 10 −11 to 10 −10 s was estimated based on the 8.5 to 1 ratio of α-to β-methyl-deoxyribose 5-phosphate formed in the presence of 50% methanol as the nucleophile (112) . The DNA repair enzyme MutY, which hydrolyzes adenine from 8-oxo-G:A mismatches, is also reported to form a deoxyribocation intermediate with a lifetime of less than 10 −10 s (113). As human PNP is known to form a fully developed ribocation at the transition state, computational studies have been employed to investigate the lifetime of the ribocation and the accompanying reaction coordinate motion. As competitive, intrinsic KIEs are a two-state comparison (reactants free in solution are compared to the transition state), temporal and reaction coordinate information is not provided, and computational chemistry approaches are needed to provide additional insights.
Purine Nucleoside Phosphorylase Transition-State Motion and Lifetime
Transition path sampling is an unbiased computational method used to locate transition states in complex systems (114, 115) . Recently, it has been applied to the chemical steps of lactate dehydrogenase and human PNP (116) . Starting conditions are provided by the crystal structure of PNP with transition-state analogs at the catalytic sites. That this model is a reliable estimate of the geometry near the transition state is supported by the high success rate of unbiased barrier crossings using this method (17) . Results of 220 barrier crossings show some common features associated with the transition state. Early loss of the ribosidic bond forms a ribocation transition state, followed by dynamic local motion of the enzyme and the ribosyl group, causing migration of the anomeric carbon toward bound phosphate to form ribose 1-phosphate. Common features identified by transition path sampling are (a) compression of the O4 . . .O5 vibrational motion linked to ribocation formation, (b) optimized leaving group interactions, and (c) activation of the phosphate nucleophile as the reaction proceeds through the transition-state region. This complex reaction coordinate is complete in approximately 70 femtoseconds (fs), with the transition-state lifetime being only 10 fs (Figure 16 ). An important conclusion of this study is that simultaneous optimization of the effects needed to reach the transition state occur on the femtosecond timescale and require coincident interactions for simultaneous ribocation formation and leaving group activation.
Test of the Reactive Intermediate Hypothesis for Human Purine Nucleoside Phosphorylase
The 10 fs transition-state lifetime (10 −14 s) for human PNP is on the timescale of a single bond vibration and cannot be considered an intermediate. Because the diffusion of water is approximately 1Å per picosecond (ps) (10 −12 s), water would be unlikely to react with an enzyme-generated ribocation when phosphate is in the vicinity if the computational lifetime of 10 fs is valid. If the lifetime of the ribocation is longer, for example, 10 −10 s (100 ps), water diffusion could easily capture the ri- 
Figure 15
Transition-state structures of Plasmodium falciparum (PfOPRT) and human (HsOPRT) for the pyrophosphorolysis of orotidine. The reaction coordinate bond distances are shown above, and the electrostatic potential maps are shown below (red is electron rich, purple is electron deficient) (reprinted from Reference 108 with permission). TS, transition state.
bocation provided that solvent has access to the catalytic site. Human PNP, like many enzymes, has hydrophobic groups that cover the catalytic site as a result of the loop motion associated with substrate binding. One interpretation of burying substrates into enzymatic catalytic sites is to shield reactive intermediates from solvent. This hypothesis was tested for human PNP by systematically removing four amino acid residues that sequester bound inosine in the catalytic site from solvent water (117) . Solvent leaks were introduced into the catalytic site by replacing individual catalytic site-sequestering amino acids with glycine. Reactivity of the ribocation transition state was tested for capture by water relative to phosphate in the glycine mutants. NMR was used to follow ribose and ribose 1-phosphate formation for approximately 10 6 catalytic cycles. Without phosphate, the phosphate-binding site fills with water, and inosine is hydrolyzed by native PNP as well as by the "leaky" Y88G, F159G, H257G, and F200G enzymes. Hydrolysis did not occur in any of the leaky mutants when phosphate is bound despite the solvents' access to the catalytic site. The result supports a ribocation lifetime too short to permit water diffusion into the catalytic site, a time estimated to be <5 ps (117) .
BEYOND N-RIBOSYLTRANSFERASES
An unprecedented N9-to-N3 isomerization of inosine is catalyzed by H257G and F200G in the presence of phosphate and by all PNPs in the absence of phosphate. Expansion of the catalytic site permits ribocation formation with relaxed geometric constraints, permitting nucleophilic rebound and N3-inosine isomerization (Figure 17) .
Thermodynamics of Transition-State Analog Binding
Thermodynamic views of enzymatic transitionstate theory suggest that the limiting affinity for binding transition-state analogs is the substrate affinity enhanced by magnitude of the enzymatic rate enhancement (118, 119) . For PNP, the limiting dissociation constant is estimated to be 6 × 10 −18 M based on the rate of spontaneous cleavage of the glycosidic bond of adenosine (120), equivalent to a G binding of −23.6 kcal/mol. This value assumes a perfect mimic of the transition state, a physical impossibility because the transition state has nonequilibrium bond lengths and angles.
Transition-state analog binding to human PNP has picomolar affinity, and the thermodynamics of binding to the first catalytic site have been analyzed by isocalorimetry (121) . Inhibitor binding exhibits negative cooperativity, and inhibition of PNP catalytic activity is complete when the inhibitor binds to the first of the three subunits. Binding of the structurally rigid first-generation ImmH (K d = 56 pM) is driven by negative enthalpy of H = −21.2 kcal/mol, teasingly close to the limit for a perfect transition-state analog, a G binding of −23.6 kcal/mol. The H of −21.2 kcal/mol is significantly greater than the H of 18.6 kcal/mol or G of 14.3 kcal/mol measured for k cat during the chemical step of PNP (122) . However, an entropic (-T S) penalty of 7.1 kcal/mol for ImmH binding provides a G binding of −14.1 kcal/mol, almost exactly matching the G for k cat .
DADMe-ImmH (K d = 9 pM) has increased conformational flexibility compared to ImmH, and it binds with a reduced entropic penalty 
Figure 18
Thermodynamics of transition-state barrier crossing compared to transition-state analog binding for DADMe-ImmA and human purine nucleoside phosphorylase (PNP). The upper portion of the plot (red ) reports the thermodynamics for the chemical step (single-turnover kinetics), and the lower portion (blue) reports the energetic signature of transition-state analog binding to the first catalytic site of human PNP-PO 4 . Numerical values are in kcal/mol. E, PNP; A, guanosine; G, Gibbs free energy; H, enthalpy; T S, entropy; I, DADMe-ImmA. of 4.3 kcal/mol but is dominated by the H of −18.6 kcal/mol (Figure 18) . The thermodynamic binding profile for DADMe-ImmH is a near perfect inverse reflection of the catalytic energy barrier. Entropic penalties arise from protein and/or inhibitor conformational loss and changes in solvent organization, but such penalties are small compared to enthalpic energy, emphasizing the large electrostatic contributions to both catalysis and inhibitor binding. H/D exchange and sedimentation velocity confirmed that ImmH, with a large entropy penalty, forms the least dynamic and structurally tightest complex with human PNP (123) . DATMe-ImmH, a highly flexible inhibitor, shows a smaller entropic penalty of 2.3 kcal/mol, less than that for ImmH or DADMe-ImmH (123) . The results have implications for catalysis by suggesting that enzyme-inhibitor conformational flexibility can assist in tight binding and that tight binding of transition-state analogs is compatible with dynamic protein flexibility. Computational molecular dynamics have provided a detailed look at the conformational differences for PNP in substrate and different transition-state analog complexes (124) . The favorable contribution of entropy to barrier crossing also suggests dynamic assistance in barrier crossing.
SUBSTRATE AND TRANSITION-STATE BINDING ISOTOPE EFFECTS
The bond vibrational environment of individual atoms at enzymatic transition states is probed by KIE experiments, whereas those for binding interactions are probed by equilibrium BIEs (33, 34) . Binding isotope effects (BIEs) compared to the kinetic isotope effect (KIE) for tritium at the 5 -position of human purine nucleoside phosphorylase (PNP (Figure 19) . This unprecedented result revealed weak C5 -H distortion at the transition state and strong distortion in complexes with transition-state analogs. A dynamic model of catalysis without the need for tight binding at the transiton state is consistent with these results (125) .
CONCLUSIONS AND THE FUTURE
Enzymatic transition states are accessible with the combined use of intrinsic KIEs and computational chemistry. Molecular electrostatic potential maps of reactants at enzymatic transition states provide blueprints for the design of transition-state analogs. Several inhibitors designed by these methods are in clinical trials. These early successes in drug design support future contributions of transition-state analysis and inhibitor design to drug development. Access to transition-state analogs has also provided structural access to difficult targets and insights to thermodynamic contributions for binding and catalysis.
SUMMARY POINTS
1. Closely related enzymes with near-identical catalytic sites can form distinct transition states.
2. Transition-state analysis from kinetic isotope effects (KIEs) and computational chemistry permits the design of isozyme-specific transition-state analogs.
3. Inhibitors designed from the first principles of transition-state theory are among the most powerful noncovalent enzymatic inhibitors.
4. Transition-state analog inhibitors designed to bind to specific enzymatic targets are finding applications in clinical trials.
5. Transition-state analogs can demonstrate binding enthalpies greater than the G ‡ barrier for catalysis.
6. The purine nucleoside phosphorylase transition state has a lifetime of 10 fs (10 −14 s), whereas enzymatic complexes with transition-state analogs have lifetimes of 1 h (10 3 to 10 4 s).
7. Binding of transition-state analogs causes remarkable distortion of analogs together with the organization and stabilization of the enzymatic protein.
FUTURE ISSUES
1. How specific are transition-state analogs? Because analogs capture unique catalytic features of an enzyme, they may target either single or a few enzymes in the human catalytic repertoire.
2. Biological lifetimes of transition-state analogs are often longer than predicted by the dissociation rates of enzyme-inhibitor complexes. The mechanisms for analog recycling are not well known, do not follow the normal rules of pharmacokinetics, and will require parallel in vitro and in vivo studies. 
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